40
Participants
Start Date
May 31, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
liraglutide
Subcutaneous self-administration of liraglutide(Victoza)by pen. The starting dose is 0.6 mg once daily(day 0 to 7), followed by 1.2 mg once daily (day 8 to 35).
Placebo
University of Luebeck, Department of Neuroendocrinology, Lübeck
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
University of Luebeck
OTHER